These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 8145982)

  • 1. A comparison of the ocular hypotensive efficacy and systemic safety of 0.5% levobunolol and 2% carteolol.
    Behrens-Baumann W; Kimmich F; Walt JG; Lue J
    Ophthalmologica; 1994; 208(1):32-6. PubMed ID: 8145982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of once-daily levobunolol for glaucoma therapy.
    Rakofsky SI; Lazar M; Almog Y; LeBlanc RP; Mann C; Orr A; Lee PF; Friedland BR; Novack GD; Kelley EP
    Can J Ophthalmol; 1989 Feb; 24(1):2-6. PubMed ID: 2653592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparison of the effectiveness and safety of levobunolol and timolol in ocular hypertension and chronic open-angle glaucoma].
    Freyler H; Novack GD; Menapace R; Skorpik C; Mordaunt J; Batoosingh AL
    Klin Monbl Augenheilkd; 1988 Sep; 193(3):257-60. PubMed ID: 3070134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of once-daily levobunolol 0.25% and timolol 0.25% therapy for increased intraocular pressure.
    Silverstone D; Zimmerman T; Choplin N; Mundorf T; Rose A; Stoecker J; Kelley E; Lue J
    Am J Ophthalmol; 1991 Jul; 112(1):56-60. PubMed ID: 1882923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of twice-daily levobunolol in the treatment of elevated intraocular pressure.
    Seamone C; LeBlanc R; Saheb N; Novack G
    Can J Ophthalmol; 1988 Jun; 23(4):168-70. PubMed ID: 3293726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of the ocular hypotensive efficacy of once-daily and twice-daily levobunolol treatment.
    Rakofsky SI; Melamed S; Cohen JS; Slight JR; Spaeth G; Lewis RA; Zbrowski-Gutman L; Eto CY; Lue JC; Novack GD
    Ophthalmology; 1989 Jan; 96(1):8-11. PubMed ID: 2645553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levobunolol and metipranolol: comparative ocular hypotensive efficacy, safety, and comfort.
    Krieglstein GK; Novack GD; Voepel E; Schwarzbach G; Lange U; Schunck KP; Lue JC; Glavinos EP
    Br J Ophthalmol; 1987 Apr; 71(4):250-3. PubMed ID: 2883990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levobunolol. A three-month efficacy study in the treatment of glaucoma and ocular hypertension.
    Bensinger RE; Keates EU; Gofman JD; Novack GD; Duzman E
    Arch Ophthalmol; 1985 Mar; 103(3):375-8. PubMed ID: 3883971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular effects of topical carteolol hydrochloride and timolol maleate in patients with ocular hypertension and primary open-angle glaucoma. Night Study Group.
    Netland PA; Weiss HS; Stewart WC; Cohen JS; Nussbaum LL
    Am J Ophthalmol; 1997 Apr; 123(4):465-77. PubMed ID: 9124243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of carteolol hydrochloride 1% vs timolol maleate 0.5% in patients with increased intraocular pressure. Nocturnal Investigation of Glaucoma Hemodynamics Trial Study Group.
    Stewart WC; Cohen JS; Netland PA; Weiss H; Nussbaum LL
    Am J Ophthalmol; 1997 Oct; 124(4):498-505. PubMed ID: 9323940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of the efficacy and tolerability of 0.5% timolol maleate ophthalmic gel-forming solution QD and 0.5% levobunolol hydrochloride BID in patients with ocular hypertension or open-angle glaucoma.
    Halper LK; Johnson-Pratt L; Dobbins T; Hartenbaum D
    J Ocul Pharmacol Ther; 2002 Apr; 18(2):105-13. PubMed ID: 12002664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term ocular hypotensive effect of levobunolol: results of a one-year study.
    Ober M; Scharrer A; David R; Biedner BZ; Novack GD; Lue JC; Robins DS; Duzman E
    Br J Ophthalmol; 1985 Aug; 69(8):593-9. PubMed ID: 3893528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levobunolol. A four-year study of efficacy and safety in glaucoma treatment. The Levobunolol Study Group.
    Ophthalmology; 1989 May; 96(5):642-5. PubMed ID: 2664628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ocular hypotensive efficacy and safety of once daily carteolol alginate.
    Demailly P; Allaire C; Trinquand C;
    Br J Ophthalmol; 2001 Aug; 85(8):921-4. PubMed ID: 11466245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Efficacy and safety of long-acting carteolol 1% once daily. A double-masked, randomized study].
    Trinquand C; Romanet JP; Nordmann JP; Allaire C;
    J Fr Ophtalmol; 2003 Feb; 26(2):131-6. PubMed ID: 12660585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Ocular hypotensive effect of 1% carteolol long-acting eye drops--a double-masked, randomized phase III study in ocular hypertension or primary open-angle glaucoma patients comparing long-acting carteolol eye drops vs. current product].
    Yamamoto T;
    Nippon Ganka Gakkai Zasshi; 2007 Jun; 111(6):463-72. PubMed ID: 17601060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levobunolol. A beta-adrenoceptor antagonist effective in the long-term treatment of glaucoma. The Levobunolol Study Group (Appended).
    Ophthalmology; 1985 Sep; 92(9):1271-6. PubMed ID: 2865710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levobunolol and betaxolol. A double-masked controlled comparison of efficacy and safety in patients with elevated intraocular pressure.
    Long DA; Johns GE; Mullen RS; Bowe RG; Alexander D; Epstein DL; Weiss MJ; Masi RJ; Charap AD; Eto CY
    Ophthalmology; 1988 Jun; 95(6):735-41. PubMed ID: 3062529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term evaluation of 0.25% levobunolol and timolol for therapy for elevated intraocular pressure.
    Boozman FW; Carriker R; Foerster R; Allen RC; Novack GD; Batoosingh AL
    Arch Ophthalmol; 1988 May; 106(5):614-8. PubMed ID: 3282501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of carteolol and timolol on plasma lipid profiles in older women with ocular hypertension or primary open-angle glaucoma.
    Stewart WC; Dubiner HB; Mundorf TK; Laibovitz RA; Sall KN; Katz LJ; Singh K; Shulman DG; Siegel LI; Hudgins AC; Nussbaum L; Apostolaros M
    Am J Ophthalmol; 1999 Feb; 127(2):142-7. PubMed ID: 10030554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.